Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ascendis Pharma ADR
(NQ:
ASND
)
144.83
+2.73 (+1.92%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
220,120
Open
143.30
Bid (Size)
121.00 (1)
Ask (Size)
154.95 (1)
Prev. Close
142.10
Today's Range
143.30 - 147.45
52wk Range
66.03 - 161.00
Shares Outstanding
57,152,295
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
$1000 Invested In Ascendis Pharma 15 Years Ago Would Be Worth This Much Today
April 18, 2024
Via
Benzinga
Week In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion
April 06, 2024
ProfoundBio will be acquired by Copenhagen’s Genmab A/S in a $1.8 billion all-cash deal. The acquisition will expand Genmab’s drug portfolio, including three ProfoundBio clinical stage ADC candidates...
Via
Talk Markets
Performance
YTD
+13.57%
+13.57%
1 Month
+0.26%
+0.26%
3 Month
+7.95%
+7.95%
6 Month
+66.20%
+66.20%
1 Year
+81.56%
+81.56%
More News
Read More
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
April 03, 2024
Via
Benzinga
Here's How Much $100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
March 14, 2024
Via
Benzinga
5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
March 09, 2024
Via
Talk Markets
These Five Small-Cap Stocks Under The Radar Are Expected To Surge, Says Stock Researcher
March 03, 2024
Via
Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $45,000 Today
February 23, 2024
Via
Benzinga
How Is The Market Feeling About Ascendis Pharma?
February 13, 2024
Via
Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $70,000 Today
February 08, 2024
Via
Benzinga
Earnings Scheduled For February 7, 2024
February 07, 2024
Via
Benzinga
Ascendis Pharma's Earnings: A Preview
February 06, 2024
Via
Benzinga
$100 Invested In Ascendis Pharma 5 Years Ago Would Be Worth This Much Today
February 02, 2024
Via
Benzinga
Ascendis Pharma's Growth Hormone Deficiency Candidate Outperforms in Phase 3 Trial
December 19, 2023
Via
Benzinga
Analyst Expectations for Ascendis Pharma's Future
November 09, 2023
Via
Benzinga
Recap: Ascendis Pharma Q3 Earnings
November 07, 2023
Via
Benzinga
Preview: Ascendis Pharma's Earnings
November 06, 2023
Via
Benzinga
The Latest Analyst Ratings for Ascendis Pharma
October 09, 2023
Via
Benzinga
The Latest Analyst Ratings for Ascendis Pharma
September 07, 2023
Via
Benzinga
Earnings Preview For Ascendis Pharma
September 04, 2023
Via
Benzinga
Analyst Expectations for Ascendis Pharma's Future
July 24, 2023
Via
Benzinga
Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty
September 28, 2023
Via
Benzinga
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
September 05, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Earnings Scheduled For September 5, 2023
September 05, 2023
Via
Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Ascendis, Alvotech, Shift4, and Waldencast and Encourages Investors to Contact the Firm
June 30, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Zai Lab, Hayward, Ascendis, and Alvotech and Encourages Investors to Contact the Firm
June 25, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.